Nobel Prize Recognizes Groundbreaking Immune System Discoveries

This year's Nobel Prize in Physiology or Medicine has been awarded for revolutionary discoveries that clarify how the body's defense network targets harmful infections while protecting the healthy tissues.

Three esteemed scientists—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—share this honor.

Their work uncovered specialized "security guards" within the defense system that eliminate malfunctioning immune cells that could attacking the body.

The discoveries are now enabling innovative treatments for immune disorders and malignancies.

The laureates will divide a prize fund valued at 11m SEK.

Decisive Discoveries

"The work has been decisive for understanding how the body's defenses functions and why we do not all develop severe autoimmune diseases," stated the head of the award panel.

The team's research explain a core question: In what way does the defense system defend us from countless invaders while keeping our healthy cells unharmed?

Our body's protection system employs immune cells that search for signs of disease, even pathogens and bacteria it has not met before.

These cells utilize detectors—called receptors—that are generated randomly in countless variations.

This gives the defense network the ability to combat a wide array of invaders, but the randomness of the mechanism inevitably creates immune cells that can target the body.

Protectors of the Body

Scientists earlier knew that a portion of these problematic defense cells were eliminated in the thymus—where white blood cells develop.

The latest Nobel Prize recognizes the identification of regulatory T-cells—known as the immune system's "security guards"—which travel through the body to neutralize any immune cells that assault the body's own tissues.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

The Nobel panel added, "The findings have laid the foundation for a new field of investigation and accelerated the development of new treatments, for instance for tumors and autoimmune diseases."

In malignancies, T-regs prevent the system from attacking the tumor, so research are aimed at reducing their numbers.

For autoimmune diseases, trials are exploring increasing T-reg cells so the organism is not being harmed. A comparable approach could also be effective in reducing the risks of transplanted organ failure.

Pioneering Experiments

Prof Sakaguchi, from a Japanese institution, conducted tests on mice that had their thymus removed, causing self-attack conditions.

The researcher demonstrated that injecting immune cells from healthy animals could stop the disease—suggesting there was a system for blocking immune cells from harming the host.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in rodents and people that resulted in the discovery of a gene vital for the way T-regs operate.

"The groundbreaking work has uncovered how the body's defenses is kept in check by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a prominent physiology expert.

"The research is a remarkable example of how basic biological study can have broad implications for human health."